SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : T/FIF, a New Plateau -- Ignore unavailable to you. Want to Upgrade?


To: scaram(o)uche who wrote (1307)7/26/2002 10:16:01 PM
From: JOEBT1  Respond to of 2243
 
Rick--In the pancreatic cancer PIII trial, one group takes G17DT plus Gemcitabine and the other group takes Gemcitabine plus a placebo. Your skepticism is probably well founded--I'll track it for a while and see what develops. Thanks for your input(and NBSC-I got out at 10+). Good hunting.
Joe